Live feed08:00:00·21hPRReleasevia QuantisnowArrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal PharmaceuticalsByQuantisnow·Wall Street's wire, on your screen.ARWR· Arrowhead Pharmaceuticals Inc.MDGL· Madrigal Pharmaceuticals Inc.Health Care
